NEUROPROTECTIVE TREATMENT IN ACUTE ISCHEMIC STROKE
Keywords:
stroke; neuroprotection; inflamation; ischemic conditioningAbstract
The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke in the era of active introduction of reperfusion treatment methods. The main mechanisms of brain damage during ischemia/reperfusion and the leading neuroprotective strategies studied in clinical trials are considered. Neuroprotective approaches aimed at suppressing excitotoxicity, oxidative stress, and neuroinflammation are presented. Current data on the safety and efficacy of uric acid, edaravone, fingolimod, natalizumab, interleukin 1 receptors antagonists, cerebrolysin, and other drugs have been analyzed. Non-drug methods of neuroprotection are characterized, including remote ischemic conditioning, therapeutic hypothermia, and neurostimulation. According to the author's position, the safest and most effective neuroprotective agent in acute ischemic stroke is neuroprotective treatment.
References
G.A. Donnan, M. Fisher, M. Macleod, et al., Stroke. Lancet Lond Engl. 371 (9624) (2008) 1612–1623
S.D. Reed, S.C. Cramer, D.K. Blough, et al., Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals, Stroke 32 (8) (2001) 1832–1840.
J.L. Saver, R. Jahan, E.I. Levy, et al., Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial, Lancet Lond Engl. 380 (9849) (2012) 1241–1249.
R.G. Nogueira, H.L. Lutsep, R. Gupta, et al., Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial, Lancet Lond Engl. 380 (9849) (2012) 1231–1240.
J. Minnerup, B.A. Sutherland, A.M. Buchan, et al., Neuroprotection for stroke: current status and future perspectives, Int J Mol Sci 13 (9) (2012) 11753–11772.
A.R. Green, Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly, Br J Pharmacol 153 (Suppl.1) (2008) S325–338.
Review Manager (RevMan) [Computer program]. Version 5.3, The Nordic Cochrane Centre. The Cochrane Collaboration, Copenhagen, 2014. [8] N. Garrido-Mesa, A. Zarzuelo, J. Gálvez, Minocycline: far beyond an antibiotic, Br J Pharmacol 169 (May (2)) (2013) 337–352.
Д.К. Хайдарова, А.У. Самадов. Совершенствование нейропротекторной терапии при остром ишемическом инсульте. Журнал "Медицина и инновации. №3. 2021. С. 92-98.
Khodjieva D. T. Review clinical assessment of the manifestations of social disadaptation in patients with cerebral stroke. Journal of Critical Reviews. 2020. Р 203-204
JurayevA.M., Khalimov R.J. New methods for surgical treatment of Perthes Disease in children. International Journal of Psychosocial Rehabilitation, Vol 24, Issue 02, 2020. Р.301-307
R. Dj.Khalimov, A.M.Djurayev, Kh.R. Rakhmatullayev Rehabilitation Program For Children Withperthes Disease. Turkish Journal of Physiotherapy and Rehabilitation. 32(3).2021. Р.18403 – 18406
AM Dzhuraev, RD Khalimov Our experience in the surgical treatment of Perthes disease in children. Postgraduate Physician 2012. N1.3 Том 50.Р. 377-383.
N. Matsukawa, T. Yasuhara, K. Hara, et al., Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke, BMC Neurosci 10 (2009) 126.
H.F. Elewa, H. Hilali, D.C. Hess, et al., Minocycline for short-term neuroprotection, Pharmacotherapy 26 (4) (2006) 515–521.
Khaydarova Dildora Kadirovna, Samadov Alibek Uktamovich. Pharmacodynamic Properties Of Some Non-Neuroprotective Drugs Widely Used In The Treatment Of Ischemic Stroke. Turkish Journal of Physiotherapy and Rehabilitation. 2021
Akramova D., Rakhimbaeva G., Vakhabova N. &Akramova., N.(2017). Stroke incidence and association with risk factorsin women in Uzbekistan //CEREBROVASCULAR DISEASES. – Т. 43.
M.V. Padma Srivastava, A. Bhasin, R. Bhatia, A. Garg, S. Gaikwad, K. Prasad, et al., Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial, Neurol India 60 (1) (2012) 23–28.
Akramova D., Rakhimbayeva G., Akramova N. The frequency or vascular parkinsonism in early and< bold> late stages of Stroke //CEREBROVASCULAR DISEASES. – ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND : KARGER, 2018. – Т. 45. – С. 199-199.
Khaydarov N. K. Khodjieva D. T., Khaydarova D. K. New Technologies in Treatment of Patients in the Acute Period of Stroke. American Journal of Medicine and Medical Sciences. Р.393-396. 2020.
] Akramova D., Rakhimbayeva G., Narzikulova M. Clinical research-lipid spectrum of blood serum at ischemic stroke against the methabolic syndrome //CEREBROVASCULAR DISEASES. – ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND : KARGER, 2018. – Т. 45. – С. 376-376.
M.R. Amiri-Nikpour, S. Nazarbaghi, M. Hamdi-Holasou, et al., An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect, Acta Neurol Scand. 131 (1) (2015) 45–50.
E. Kohler, D.A. Prentice, T.R. Bates, et al., Intravenous minocycline in acute stroke: a randomized, controlled pilot study and meta-analysis, Stroke. 44 (9) (2013) 2493–2499.
Akramova D., Gazieva S. The role of the inconsistency of connective tissue in the development of pathological deformations of cerebral vessels in patients with primary headaches //CEREBROVASCULAR DISEASES. – ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND : KARGER, 2018. – Т. 45. – С. 485-485.
Kadirovna, K. D., Kadirovich, X. N., & Tadjiyevna, K. D. (2022). Clinical basis for the development of neuroprotective therapy in acute ischemic stroke. International Journal of Health Sciences, 6(S1), 4177–4183. https://doi.org/10.53730/ijhs.v6nS1.5819
Akramova D., Rakhimbaeva G. Role of cerebral perfusion in development of vascular parkinsonism //CEREBROVASCULAR DISEASES. – ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND : KARGER, 2017. – Т. 43.
Khaуdarova Dildora Kadirovna, Samadov Alibek Uktamovich. Optimization of neuroprotective therapy for ischemic stroke in the acute period. Журнал неврологии и нейрохирургических исследований. №3. 2020 С. 13-15.
